These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. GM giants pair up to do battle. Mitchell P Nat Biotechnol; 2007 Jul; 25(7):695-6. PubMed ID: 17621277 [No Abstract] [Full Text] [Related]
11. The biotechnology bubble machine. Rasnick D Nat Biotechnol; 2003 Apr; 21(4):355-6. PubMed ID: 12665813 [No Abstract] [Full Text] [Related]
12. [Doctors, scientists and patients confront human biological materials research]. Dubreuil C; Duchier J; Cambon-Thomsen A Rev Prat; 2001 Mar; 51(5):469-72. PubMed ID: 11345552 [No Abstract] [Full Text] [Related]
13. Recombinant DNA markets may exceed $3 billion by 1990. Am Pharm; 1981 Feb; NS21(2):18. PubMed ID: 6938124 [No Abstract] [Full Text] [Related]
14. Enhancement technology, ethics, and public policy. Sade RM J S C Med Assoc; 1998 Sep; 94(9):411-5. PubMed ID: 9780577 [No Abstract] [Full Text] [Related]
15. Rethinking US leadership in food biotechnology. Taylor MR Nat Biotechnol; 2003 Aug; 21(8):852-4. PubMed ID: 12894194 [No Abstract] [Full Text] [Related]
16. Genomic sciences and the medicine of tomorrow. Drews J Nat Biotechnol; 1996 Nov; 14(11):1516-8. PubMed ID: 9634812 [No Abstract] [Full Text] [Related]
17. Genetic engineering of millets: current status and future prospects. Ceasar SA; Ignacimuthu S Biotechnol Lett; 2009 Jun; 31(6):779-88. PubMed ID: 19205896 [TBL] [Abstract][Full Text] [Related]
18. Unlocking the money-making potential of RNAi. Howard K Nat Biotechnol; 2003 Dec; 21(12):1441-6. PubMed ID: 14647324 [No Abstract] [Full Text] [Related]
20. A Protestant perspective on the new genetics: are people and institutions of faith prepared to lead? Jones JC St Thomas Law Rev; 2001; 13(4):927-34. PubMed ID: 12661582 [No Abstract] [Full Text] [Related] [Next] [New Search]